Shots:

• Medtronic to acquire all outstanding shares of Medicrea along with its MEDICREA UNiD ASI for about $7.98/ share with a premium of 22% over the closing price of shares on Jul 14- 2020. The acquisition is expected to be closed at the end of 2020
• Medtronic has commitments to buy 44.4% of Medicrea’s current outstanding share capital. The acquisition enables Medtronic to become the first company to offer AI-driven surgical planning- personalized spinal implants- and robotic-assisted surgical delivery
• Assimilation of Medicrea’s capabilities and solutions in data analytics- AI and personalized implants with Medtronic’s portfolio of spine implants- robotics- navigation- and 3D imaging technology improves Medtronic’s procedural solution for surgical planning and delivery

  Ref: Businesswire | Image: OrthoSpineNews